Previous 10 | Next 10 |
Humanigen (HGEN) has collaborated with Thermo Fisher Scientific (TMO) to expand the manufacturing capacity for lenzilumab, for use in COVID-19, to support a potential Emergency Use Authorization ((EUA)). "Manufacturing preparation, precision and expertise are critical as we execute on an aggr...
Collaboration further strengthens manufacturing capabilities and capacity in advance of potential Emergency Use Authorization in 2020 Humanigen, Inc. , (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing an...
Management presentation Wednesday, September 23 at 10:50 a.m. EDT Humanigen, Inc. , (Nasdaq: HGEN) (“Humanigen”), announced today that management will present a company overview and business update at the Oppenheimer Fall Healthcare Life Sciences & MedT...
Humanigen, Inc. (Nasdaq: HGEN), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate lenzilumab™, announced today that it has completed its previously announce...
Gainers: Cubic (CUB) +30%.AcelRx Pharmaceuticals (ACRX) +23%.VerifyMe (VRME) +22%.Cardiff Oncology (CRDF) +19%.Roku (ROKU) +16%.Trinity Place (TPHS) +14%.Super League Gaming (SLGG) +12%.Humanigen (HGEN) +12%.CleanSpark (CLSK) +12%.MicroVision (MVIS) +11%.Losers: Condor Hospitality T...
Gainers: AcelRx Pharmaceuticals (ACRX) +17%, Cardiff Oncology (CRDF) +16%, Humanigen (HGEN) +14%, Medicenna Therapeutics (MDNA) +11%, Orgenesis (ORGS) +7%.Losers: iCAD (ICAD) -21%, Pieris Pharmaceuticals (PIRS) -19%, Legend Biot...
Humanigen ( OTCQB:HGEND ) has priced its public offering of 8M common shares at $8.50/share, resulting in gross proceeds of ~$68M. More news on: Humanigen, Inc., HUMANIGEN INC NEW, Healthcare stocks news, , Read more ...
Humanigen, Inc. (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate lenzilumab, announced today that it has priced its underwritten public offer...
Note: This article was published on our blog on September 13, 2020 More than meets the AudioEye - PM Summary AudioEye ( AEYE ) is a software-as-a-service ( SAAS ) company that provides website accessibility compliance – in plain English, it claims to use machine learning/AI to...
Humanigen ( OTCQB:HGEN ) -1% announced that it has commenced an underwritten public offering of 8M shares of common stock. More news on: Humanigen, Inc., , Healthcare stocks news Read more ...
News, Short Squeeze, Breakout and More Instantly...
Williams Industrial Services Group Inc. (WLMSQ) is expected to report $-0.15 for Q3 2023 Cellcom Israel Limited (CELJF) is expected to report for quarter end 2023-09-30 Central Japan Railway Co ADR (CJPRY) is expected to report for Q2 2024 CW Petroleum Corp (CWPE) is expected to repor...
Strategic Environmental & Energy Resources Inc (SENR) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-09-30 Lanvin Group Holdings Limited (LANV) is expected to...
Murata Manufacturing Co. Ltd. ADR (MRAAY) is expected to report $0.27 for Q2 2024 Quotient Limited (QTNTQ) is expected to report for quarter end 2023-09-30 Evaxion Biotech A/S (EVAX) is expected to report for Q3 2023 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to repo...